Table 2—

Human immunodeficiency virus (HIV)‐specific demographic data

Patient No.Age yrsSexBaseline CD4 cells·µL−1Baseline HIV RNA copies·mL−1CDC classificationAntiretroviral therapyHIV infectionOpportunistic infections
OngoingPreviousStartYearRisk factors/sexual habits
131F748<50B1AZT+3TC+ABCNoneOct. 19991986IVDUNone
229F710<50C2AZT+3TC+EFVD4T+3TC+NFVJul. 19981998HeterosexualPCP (1998 and 1999)
AZT+3TC+EFV
341F266300B23TC+D4T+NFVNoneApr. 19981984IVDUNone
441F820<50B2AZT+3TC+EFVAZT+3TC+IDV19971993HeterosexualNone
AZT+3TC+RTV+IDV
3TC+D4T+NFV
534M60030000B1NoneNone1986IVDUNone
651M12220000B33TC+D4T+RTV+IDV+NFVAZTAug. 19891984HeterosexualNone
AZT+DDC
AZT+3TC
D4T+3TC+SQV
D4T+3TC+NVP+IDV
743M152<50B3AZT+3TC+ABCAZT+3TC+IDVMar. 19971986IVDUNone
D4T+DDI+HU+NVP
836F366<50B2AZT+3TC+ABCNone19991991IVDUNone
  • RNA: ribonucleic acid

  • CDC: Centers for Disease Control and Prevention

  • F: female

  • M: male

  • AZT: azidothymidine

  • 3TC: lamivudine

  • ABC: abacavir

  • EFV: efavirenz

  • D4T: stavudine

  • NFV: nelfinavir

  • RTV: ritonavir

  • IDV: indinavir

  • DDC: zalcitabine

  • SQV: saquinavir

  • DDI: didanosine

  • HU: hydroxyurea

  • NVP: nevirapine

  • IVDU: intravenous drug use

  • PCP: Pneumocystis carinii pneumonia